These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 3002440

  • 21. Cooperative sequestration of m-AMSA in L1210 cells.
    Zwelling LA, Kerrigan D, Michaels S, Kohn KW.
    Biochem Pharmacol; 1982 Oct 15; 31(20):3269-77. PubMed ID: 6897359
    [Abstract] [Full Text] [Related]

  • 22. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA, Kerrigan D, Michaels S.
    Cancer Res; 1982 Jul 15; 42(7):2687-91. PubMed ID: 6896293
    [Abstract] [Full Text] [Related]

  • 23. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.
    Jensen PB, Sørensen BS, Demant EJ, Sehested M, Jensen PS, Vindeløv L, Hansen HH.
    Cancer Res; 1990 Jun 01; 50(11):3311-6. PubMed ID: 2159380
    [Abstract] [Full Text] [Related]

  • 24. Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells.
    Woynarowski JM, McNamee H, Szmigiero L, Beerman TA, Konopa J.
    Biochem Pharmacol; 1989 Nov 15; 38(22):4095-101. PubMed ID: 2557039
    [Abstract] [Full Text] [Related]

  • 25. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y, Kerrigan D, Schwartz RE, Swack JA, McCurdy A.
    Cancer Res; 1986 Jun 15; 46(6):3075-81. PubMed ID: 3009009
    [Abstract] [Full Text] [Related]

  • 26. Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
    Multon E, Riou JF, LeFevre D, Ahomadegbe JC, Riou G.
    Biochem Pharmacol; 1989 Jul 01; 38(13):2077-86. PubMed ID: 2544183
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
    Lefevre D, Riou JF, Ahomadegbe JC, Zhou DY, Benard J, Riou G.
    Biochem Pharmacol; 1991 Jun 15; 41(12):1967-79. PubMed ID: 1645555
    [Abstract] [Full Text] [Related]

  • 30. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.
    Yang L, Rowe TC, Nelson EM, Liu LF.
    Cell; 1985 May 15; 41(1):127-32. PubMed ID: 2986841
    [Abstract] [Full Text] [Related]

  • 31. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M, Chan D, Freireich EJ, Marton LJ, Zwelling LA.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [Abstract] [Full Text] [Related]

  • 32. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
    Kong XB, Rubin L, Chen LI, Ciszewska G, Watanabe KA, Tong WP, Sirotnak FM, Chou TC.
    Mol Pharmacol; 1992 Feb 15; 41(2):237-44. PubMed ID: 1311406
    [Abstract] [Full Text] [Related]

  • 33. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
    Estey EH, Silberman L, Beran M, Andersson BS, Zwelling LA.
    Biochem Biophys Res Commun; 1987 Apr 29; 144(2):787-93. PubMed ID: 3034264
    [Abstract] [Full Text] [Related]

  • 34. Reconstitution of intercalator-induced DNA scission by an active component from nuclear extracts.
    Filipski J, Yin J, Kohn KW.
    Biochim Biophys Acta; 1983 Oct 13; 741(1):116-22. PubMed ID: 6688534
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.
    Zwelling LA, Estey E, Silberman L, Doyle S, Hittelman W.
    Cancer Res; 1987 Jan 01; 47(1):251-7. PubMed ID: 3024817
    [Abstract] [Full Text] [Related]

  • 38. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S, Riou G.
    Biochem Pharmacol; 1994 Aug 30; 48(5):975-84. PubMed ID: 8093110
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.
    Pommier Y, Zwelling LA, Kao-Shan CS, Whang-Peng J, Bradley MO.
    Cancer Res; 1985 Jul 30; 45(7):3143-9. PubMed ID: 2988762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.